ANL ▲ +0.3% - Adlai Nortye Group Ltd.
$ANL - Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab
15-OCT-2026 07:00 AM ET
Share this post
More filings for $ANL
ANL ▼ -1.1% - Adlai Nortye Group Ltd.Sep 10, 2026ANL - Adlai Nortye Ltd. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $ANL filing history →💬 Comments
Loading comments…
Leave a comment